Achilles Therapeutics plc (ACHL) Earnings
|
Expand Research on ACHL
| Next EPS Date | 5/7/24 | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +16.8% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -1.3% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5/7/24 | Q124 | N/A | -$0.56 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 2/27/24 | Q423 | N/A | -$0.15 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/11/24 | Q423 | N/A | -$0.15 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/18/24 | Q423 | N/A | -$0.15 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/25/24 | Q423 | N/A | -$0.15 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/7/23 | Q323 | N/A | -$0.40 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/13/23 | Q323 | N/A | -$0.40 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/4/23 | Q223 | N/A | -$0.42 | N/A | N/A | N/A | N/A | N/A | N/A |
